Rapid Quantum Magnetic IL-6 Point-of-Care Assay in Patients Hospitalized with COVID-19

Interleukin-6 (IL-6) has been linked to several life-threatening disease processes. Developing a point-of-care testing platform for the immediate and accurate detection of IL-6 concentrations could present a valuable tool for improving clinical management in patients with IL-6-mediated diseases. Dra...

Descripción completa

Detalles Bibliográficos
Autores principales: Atallah, Johnny, Archambault, Dakota, Randall, Jeffrey D., Shepro, Adam, Styskal, Lauren E., Glenn, David R., Connolly, Colin B., Katsis, Katelin, Gallagher, Kathleen, Ghebremichael, Musie, Mansour, Michael K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139897/
https://www.ncbi.nlm.nih.gov/pubmed/35626318
http://dx.doi.org/10.3390/diagnostics12051164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139897/
https://www.ncbi.nlm.nih.gov/pubmed/35626318
http://dx.doi.org/10.3390/diagnostics12051164

Ejemplares similares